Search Results
Oct 14, 2025, 08:00 ET King Risk Partners Extends Virginia Footprint Through Acquisition of Jenkins Insurance
GAINESVILLE, Fla., Oct. 14, 2025 /PRNewswire/ -- King Risk Partners, the 51st largest insurance brokerage in the United States, is delighted to announce its acquisition of Jenkins Insurance, a well-respected independent agency
More news about: King Risk Partners
Oct 14, 2025, 08:00 ET Oklahoma Cancer Specialists and Research Institute (OCSRI) Partners with IDEOlogy Health to Bring Cutting-Edge Education to Oncologist Providers
OCSRI was formed in 2016 in partnership with Ascension St. John Medical Center and exists to provide the highest level of comprehensive cancer care. OCSRI is driven by its compassion for patients and their families,
More news about: IDEOlogy Health
Oct 14, 2025, 07:10 ET Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy & Behavior
inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), bupropion, triptans, dietary supplements (e.g., St. John's Wort, tryptophan), drugs that impair metabolism of serotonin (including monoamine oxidase inhibitors [MAOIs], which are contraindicated with FINTEPLA),
More news about: UCB
Oct 14, 2025, 06:55 ET Ameren Corporation announces leadership changes
Moehn, Singh, Smith promoted to new roles ST. LOUIS, Oct. 14, 2025 /PRNewswire/ -- Ameren Corporation (NYSE: AEE) today announced organizational changes
More news about: Ameren Corporation
Oct 14, 2025, 06:00 ET Realtor.com®: Renters Now Spend Less than a Quarter of Their Income on Rent
Minneapolis-St. Paul- Bloomington,
More news about: Realtor.com
Oct 14, 2025, 05:02 ET Zero Point Motion appoints Pascal Langlois as new Chair
took the company to IPO on the Euronext stock exchange and later secured a trade sale to TDK Group. Pascal has also held senior executive roles at ST-Ericsson, NXP, Philips Semiconductors and VLSI Technology, scaling high-performance solutions to high-volume production for leading global OEMs.
More news about: Zero Point Motion
Oct 14, 2025, 05:02 ET Zero Point Motion appoints Pascal Langlois as new Chair
took the company to IPO on the Euronext stock exchange and later secured a trade sale to TDK Group. Pascal has also held senior executive roles at ST-Ericsson, NXP, Philips Semiconductors and VLSI Technology, scaling high-performance solutions to high-volume production for leading global OEMs.
More news about: Zero Point Motion
Oct 14, 2025, 03:30 ET First patient treated with Leqembi® (lecanemab) in the Nordics
Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy. About the collaboration between
More news about: BioArctic
Oct 14, 2025, 02:00 ET Codis Launches as Global CDMO for Commercial Spray Drying and Amorphous Solid Dispersions
and problem-solving orientation ST. LOUIS, Oct. 14, 2025 /PRNewswire/ -- Codis officially launches as a new global CDMO specializing in commercial-scale
More news about: Codis
Oct 14, 2025, 02:00 ET Codis Launches as Global CDMO for Commercial Spray Drying and Amorphous Solid Dispersions
and problem-solving orientation ST. LOUIS, Oct. 14, 2025 /PRNewswire/ -- Codis officially launches as a new global CDMO specializing in commercial-scale
More news about: Codis
Oct 14, 2025, 01:18 ET Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025
Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy. About the collaboration between
More news about: BioArctic
Oct 14, 2025, 01:14 ET Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025
Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy. About the collaboration between
More news about: BioArctic
Oct 13, 2025, 19:30 ET LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy. About
More news about: Eisai Inc.
Oct 13, 2025, 16:55 ET TAYLOR SWIFT'S 'The Life of a Showgirl' EARNS BIGGEST FIRST WEEK IN MUSIC HISTORY WITH OVER 4 MILLION U.S. AND OVER 5.5 MILLION GLOBAL ALBUM EQUIVALENT UNITS
for any album in US music history. Marks Swift's 15th No. 1 album, breaking the record for the most No. 1 albums in the 21st century. Sets the record for the most No. 1 albums by a solo artist. Extends her record as the
More news about: Republic Records
Oct 13, 2025, 14:20 ET Nexans new leadership: appointment of Julien Hueber to succeed Christopher Guérin as Chief Executive Officer
and to part ways with Christopher Guérin. These decisions will take effect immediately; Christopher will be available to Julien until October 31st, 2025.
More news about: Nexans
Oct 13, 2025, 14:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stride, Inc. - LRN
for information about joining the class action] On September 14, 2025, Simply Wall St. published a report stating that the Gallup-McKinley County Schools Board of Education had filed a complaint against Stride, alleging fraud,
More news about: Pomerantz LLP
Oct 13, 2025, 11:20 ET Nanomedicine Market Size to Reach US$ 389.52 Billion by 2033, Driven by Advancements in Targeted Therapies and Drug Delivery Innovations | According DataM Intelligence
disease. The U.S. National Nanotechnology Initiative (NNI), which coordinates research across 19 federal agencies under the 21st Century Nanotechnology Research and Development Act, plays a crucial role in advancing nanoscale science. By promoting basic and applied research and
More news about: DataM Intelligence 4 Market Research LLP
Oct 13, 2025, 11:11 ET Essence Healthcare named among the best performing Medicare Advantage plans for 2026
year, reflecting strong performance across all markets ST. LOUIS, Oct. 13, 2025 /PRNewswire/ -- Essence Healthcare today announced that for the 2026 plan year, it has
More news about: Essence Healthcare
Oct 13, 2025, 11:00 ET Doodie Calls Completes Fifth Acquisition, Expands Footprint in the Southeast with Pit Stop Sanitation
ST. PETERSBURG, Fla., Oct. 13, 2025 /PRNewswire/ -- Doodie Calls has announced the acquisition of Pit Stop Sanitation, a leading portable sanitation provider based in Atlanta, Georgia.
More news about: Doodie Calls
Oct 13, 2025, 10:42 ET ACHP Receives $4.2M Grant to Improve Diabetes Care and Outcomes from the Helmsley Charitable Trust
in the world with a focus on T1D, with more than $1 billion to date granted to transform the trajectory of the disease and to accelerate access to 21st century care, everywhere. For more information on Helmsley and its programs, visit helmsleytrust.org.
More news about: Alliance of Community Health Plans
Oct 13, 2025, 10:25 ET GTCR Announces Promotions and New Team Appointments Across the Organization
management roles for stressed and distressed businesses. Andrew started his career at Bear Stearns & Co. and received a BA from Washington University in St. Louis. Kirk Smith, Managing DirectorKirk joined GTCR in 2022. Prior to joining GTCR, Kirk was
More news about: GTCR
Oct 13, 2025, 10:17 ET Boehringer and Click Therapeutics present pivotal data for investigational prescription digital therapeutic CT-155 showing a statistically significant reduction in negative symptoms of schizophrenia
care," said Gregory W. Mattingly, MD, Associate Clinical Professor at Washington University in St. Louis, MO and Principal Investigator in Clinical Trials for Midwest Research Group and Founding Partner of St. Charles Psychiatric Associates. "This research underscores the importance of including innovative
More news about: Boehringer Ingelheim Pharmaceuticals, Inc.; Click Therapeutics
Oct 13, 2025, 10:00 ET Obligo Announces a New Embedded, End-to-End Solution to Fully Outsource Security Deposit Management
in over one million homes across the United States. Media Contact: Keegan St. [email protected]
More news about: Obligo
Oct 13, 2025, 09:00 ET iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data
"Company") is recognized as a biotechnology company pioneering chemically induced allogeneic cell therapy. iRegene's lead product, NouvNeu001, is the 1st iPSC therapy to receive IND approval from both the NMPA and the FDA to treat Parkinson's disease (PD). Recently, NouvNeu001 Phase I clinical data were
More news about: iRegene therapeutics
Oct 13, 2025, 09:00 ET Barilla Brings Domenica Italiana to Austin During Formula 1 MSC Cruises United States Grand Prix 2025 Weekend
tote bags with purchase while supplies last. Local Restaurant Activation: Through October 21st, locals can visit twenty Austin restaurants serving limited-edition dishes featuring Barilla's Al Bronzo, a traditional bronze-cut pasta designed
More news about: Barilla America, Inc.